Committee Chairman Sen. Lamar Alexander, R-Tenn., on Tuesday released a letter sharing plans for the drug cost meeting.
In the letter, Sen. Alexander said the meeting will “help ensure that we are operating from similar understanding of the facts about drug spending and help inform what other topics we may explore.”
A bipartisan group of lawmakers — led by committee members Sens. Bill Cassidy, R-La., and Al Franken, D-Minn. — requested the hearing, according to the report.
“Going forward, we need a comprehensive approach to identify trends related to growing drug spending, bring down overall healthcare costs, improve and reward quality, and promote innovation,” said Mr. Cassidy and Mr. Franken, according to The Hill.
More articles on supply chain:
Urine tests cost Colorado Medicaid $1M per month in 2016
EpiPens may prove effective 4 years past expiration date, researcher says
Express Scripts launches new pharmacy discount program, Inside Rx
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.